Table 2. Frequencies and costs of ambulatory medical care utilization in patients with systemic lupus erythematosus and controls over an eight-year period preceding the index date.
Years preceding index date | Annual frequencies of ambulatory medical care utilization | P | Annual costs of ambulatory medical care utilization | P | ||
Patients with SLE | Controls | Patients with SLE | Controls | |||
n = 337 | n = 1,348 | n = 337 | n = 1,348 | |||
8 | 8.31±13.23 | 4.04±9.63 | <0.001 | 232±697 | 98±454 | <0.001 |
(1, 0–13) | (0, 0–3) | (18, 0–251) | (0, 0–47) | |||
7 | 9.74±12.80 | 4.95±10.76 | <0.001 | 289±1450 | 107±288 | <0.001 |
(5, 0–15) | (0, 0–6) | (82, 0–293) | (0, 0–94) | |||
6 | 12.15±13.64 | 6.05±11.79 | <0.001 | 398±1488 | 135±407 | <0.001 |
(8, 1–18) | (0, 0–9) | (142, 13–407) | (0, 0–145) | |||
5 | 14.41±13.18 | 7.30±12.74 | <0.001 | 520±2000 | 186±848 | <0.001 |
(11, 5–20) | (1, 0–10) | (218, 73–453) | (12, 0–204) | |||
4 | 16.03±13.61 | 7.86±12.45 | <0.001 | 632±2404 | 208±903 | <0.001 |
(13, 6–23) | (2, 0–12) | (243, 93–542) | (16, 0–225) | |||
3 | 16.81±13.27 | 8.10±12.83 | <0.001 | 750±2420 | 216±893 | <0.001 |
(14, 6–23) | (2, 0–12) | (265, 110–632) | (20, 0–220) | |||
2 | 17.47±15.18 | 7.84±12.72 | <0.001 | 760±2460 | 218±949 | <0.001 |
(13, 6–25) | (1, 0–12) | (291, 109–751) | (27, 0–230) | |||
1 | 25.23±15.24 | 8.07±13.05 | <0.001 | 1134±2503 | 216±897 | <0.001 |
(22, 15–32) | (2, 0–12) | (680, 419–1186) | (27, 0–230) |
Values are mean ± standard deviation and (median, 25th–75th percentile).
Costs were converted to US dollars based on annual exchange rates and adjusted to 2010 figures based on Taiwan's consumer price index.
SLE, systemic lupus erythematosus.